Quaker Chemical CORP Form 4 insider transactions

Jeewat Bijlani, EVP, Glob. Spec. & CGO of Quaker Chemical Corp, reported a transaction in 7 shares of common stock on August 7, 2026.

William H Osborne, a Director of Quaker Chemical Corp, sold 600 shares of common stock on August 4, 2026 for $168.31 per share.

Thomas Coler, EVP and CFO of Quaker Chemical Corp, reported transactions involving restricted stock units and dividend equivalent rights.

Lucrece Foufopoulos-De Ridder, a Director at Quaker Chemical Corp, reported transactions involving common stock, including share acquisitions and surrenders for tax obligations.

Director Lucrece Foufopoulos-De Ridder reported the vesting of restricted stock units and a new equity grant for Quaker Houghton.

Mark Douglas, a Director at Quaker Chemical Corp (KWR), reported transactions involving the acquisition and disposition of common stock and restricted stock units.

Director Fay West of Quaker Chemical Corp (KWR) reported transactions involving restricted stock units and dividend equivalent rights, reflecting compensation and ownership changes.

Director Russell Shaller reported transactions involving Quaker Chemical Corp. stock, including the acquisition of restricted stock units and settlement of dividend equivalent rights.

William H. Osborne, a Director at Quaker Chemical Corp (KWR), reported transactions involving restricted stock units and dividend equivalents.

Sanjay Hinduja, a Director at Quaker Chemical Corp, has reported transactions involving restricted stock units and dividend equivalent rights.

Director Charlotte C. Henry of Quaker Chemical Corp. reported transactions involving restricted stock units and dividend equivalent rights.

Director Jeffry D. Frisby of Quaker Chemical Corp. reported transactions involving restricted stock units and dividend equivalent rights.

Nandita Bakhshi, a Director at Quaker Chemical Corp, reported transactions involving restricted stock units and dividend equivalent rights.

Quaker Houghton EVP Jeewat Bijlani exercised 731 stock options and subsequently sold the shares on May 26, 2026.

QH Hungary Holdings Ltd has amended seven variable prepaid forward sale contracts involving Quaker Chemical Corp shares.

Kevin K. Meagher, VP of R&D at Quaker Chemical, amended a previous filing to reflect a higher grant of 445 Restricted Stock Units.

Quaker Chemical Corp's VP of R&D, Andre Frodl, amended a previous filing to correct the number of Restricted Stock Units granted from 371 to 724.

Robert T. Traub, SVP, GC & Corp. Sec. of Quaker Chemical Corp, reported the vesting of performance and restricted stock units, settlement of dividend equivalent rights, and a new RSU grant on March 15, 2026.

Kristin Rokosky, SVP and CHRO of Quaker Chemical Corp, reported recent acquisitions of common stock and restricted stock units, alongside a sale to cover tax obligations.

Miguel Moreno Hernandez, SVP at Quaker Chemical, reported the vesting of performance and restricted stock units, settlement of dividend equivalent rights, and a new RSU grant.

Quaker Chemical Corp. granted 297 Restricted Stock Units to VP Kevin K. Meagher, vesting annually starting March 15, 2027.

Quaker Chemical's SVP, Ma Jun, increased direct beneficial ownership of common stock to 3,295 shares through the vesting and settlement of performance and restricted stock units, and dividend equivalent rights.

Christine Procopio Johnson, SVP and CTO of Quaker Chemical Corp, exercised restricted stock units, settled dividend equivalent rights, and received a new RSU grant.

Quaker Chemical Corp's VP of R&D, Andre Frodl, reported the vesting of performance and restricted stock units, along with tax-related share dispositions and a new RSU grant.

Steven R. Dassing, VP and Principal Accounting Officer at Quaker Chemical Corp, reported the vesting of performance and restricted stock units, settlement of dividend equivalent rights, and new RSU grants.

Quaker Chemical's EVP and CFO, Thomas Coler, reported the vesting and settlement of restricted stock units and dividend equivalent rights, alongside a new RSU grant and shares surrendered for tax obligations.

Renato Carvalho, SVP at Quaker Chemical Corp, reported the vesting of performance and restricted stock units, along with a new RSU grant and shares withheld for taxes.

An executive at Quaker Chemical Corp. reported significant equity transactions, including vesting of performance and restricted stock units, and a new RSU grant.

Michael F. Barry, a Director at Quaker Chemical Corp, exercised employee stock options and increased his direct beneficial ownership of common stock.

Kevin K. Meagher, VP of R&D at Quaker Chemical Corp., received a grant of 1,898 restricted stock units, vesting over three years.